Cargando…
Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753190/ https://www.ncbi.nlm.nih.gov/pubmed/34758063 http://dx.doi.org/10.1182/bloodadvances.2021005814 |
| _version_ | 1784632042001006592 |
|---|---|
| author | Liang, Zhiyu Li, Ping Kang, Liqing Zhou, Lili Xu, Yang Ye, Shiguang Du, Juan Li, Bing Wang, Yiwen Yu, Lei Qian, Wenbin Liang, Aibin |
| author_facet | Liang, Zhiyu Li, Ping Kang, Liqing Zhou, Lili Xu, Yang Ye, Shiguang Du, Juan Li, Bing Wang, Yiwen Yu, Lei Qian, Wenbin Liang, Aibin |
| author_sort | Liang, Zhiyu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8753190 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87531902022-01-12 Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma Liang, Zhiyu Li, Ping Kang, Liqing Zhou, Lili Xu, Yang Ye, Shiguang Du, Juan Li, Bing Wang, Yiwen Yu, Lei Qian, Wenbin Liang, Aibin Blood Adv Research Letter American Society of Hematology 2022-01-11 /pmc/articles/PMC8753190/ /pubmed/34758063 http://dx.doi.org/10.1182/bloodadvances.2021005814 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Liang, Zhiyu Li, Ping Kang, Liqing Zhou, Lili Xu, Yang Ye, Shiguang Du, Juan Li, Bing Wang, Yiwen Yu, Lei Qian, Wenbin Liang, Aibin Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma |
| title | Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma |
| title_full | Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma |
| title_fullStr | Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma |
| title_full_unstemmed | Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma |
| title_short | Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma |
| title_sort | immunoglobulin isotype switch after anti-bcma car t-cell therapy for relapsed or refractory multiple myeloma |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753190/ https://www.ncbi.nlm.nih.gov/pubmed/34758063 http://dx.doi.org/10.1182/bloodadvances.2021005814 |
| work_keys_str_mv | AT liangzhiyu immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT liping immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT kangliqing immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT zhoulili immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT xuyang immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT yeshiguang immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT dujuan immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT libing immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT wangyiwen immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT yulei immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT qianwenbin immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma AT liangaibin immunoglobulinisotypeswitchafterantibcmacartcelltherapyforrelapsedorrefractorymultiplemyeloma |